Key facts
- It has raised $22.5M; the latest was Debt - General ($50K) in Sep 2021.
- Notable investors include Bow River Capital, Morgan Stanley Private Credit, The PGIM Private Capital, Waud Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Unifeye Vision Partners
- ·The full record, as it builds
Funding rounds
No funding rounds for Unifeye Vision Partners are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Unifeye Vision Partners
Operator of a physician-led ambulatory surgery center designed to provide integrated practice management services focused on ophthalmology. The company delivers comprehensive management and support services to ophthalmology and optometry practices, including subspecialties such as cataract, cornea, glaucoma, refractive, and retina care, as well as single-specialty eye surgery centers, enabling improved patient experiences and long-term success. Today, UVP supports a network of over 170 providers, 65 clinic locations, and 20 ambulatory surgery centers.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2017
- Employees
- 65
- Website
- uvpeye.com/
- Ownership
- Privately Held (backing)
Unifeye Vision Partners doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Unifeye Vision Partners shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Unifeye Vision Partners in its N-PORT filings yet. We sweep new filings monthly.